Nicole Lambert is COO at MYRIAD GENETICS INC (MYGN). They have made 5 open-market trades across 1 company since 2020, most recently 2026-06-11.
CIK 0001770252
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYGN | SELL | 2023-03-27 | 2023-03-28 | $23.48 | $302K | +2.1% | -7.9% | -1.0% |
| MYGN | SELL | 2023-03-02 | 2023-03-03 | $22.74 | $600K | -0.3% | +1.5% | -1.3% |
| MYGN | SELL · 10b5-1 | 2021-10-01 | 2021-10-04 | $31.57 | $45K | +3.8% | -5.8% | -9.9% |
| MYGN | SELL | 2021-09-27 | 2021-09-27 | $33.10 | $669K | -1.4% | -4.6% | -14.9% |
| MYGN | SELL · 10b5-1 | 2021-08-27 | 2021-08-30 | $34.50 | $33K | -7.3% | -10.1% | -24.5% |
| MYGN | SELL | 2021-04-19 | 2021-04-20 | $27.01 | $339K | +14.6% | +3.7% | +13.7% |
| MYGN | SELL | 2020-02-12 | 2020-02-12 | $19.73 | $172K | -9.5% | -33.1% | -27.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.